- Home
- POWW vs ELTX Comparison
POWW vs ELTX Comparison
Compare POWW & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- ELTX
- Stock Information
- Founded
- POWW 1990
- ELTX 2011
- Country
- POWW United States
- ELTX United States
- Employees
- POWW N/A
- ELTX N/A
- Industry
- POWW Ordnance And Accessories
- ELTX Biotechnology: Pharmaceutical Preparations
- Sector
- POWW Industrials
- ELTX Health Care
- Exchange
- POWW Nasdaq
- ELTX Nasdaq
- Market Cap
- POWW 181.5M
- ELTX 158.5M
- IPO Year
- POWW N/A
- ELTX N/A
- Fundamental
- Price
- POWW $1.80
- ELTX $8.77
- Analyst Decision
- POWW Strong Buy
- ELTX Strong Buy
- Analyst Count
- POWW 2
- ELTX 1
- Target Price
- POWW $2.38
- ELTX $13.00
- AVG Volume (30 Days)
- POWW 430.0K
- ELTX 104.1K
- Earning Date
- POWW 11-10-2025
- ELTX 11-13-2025
- Dividend Yield
- POWW N/A
- ELTX N/A
- EPS Growth
- POWW N/A
- ELTX N/A
- EPS
- POWW N/A
- ELTX N/A
- Revenue
- POWW $46,632,638.00
- ELTX N/A
- Revenue This Year
- POWW $10.08
- ELTX N/A
- Revenue Next Year
- POWW $0.94
- ELTX N/A
- P/E Ratio
- POWW N/A
- ELTX N/A
- Revenue Growth
- POWW 1343.57
- ELTX N/A
- 52 Week Low
- POWW $0.95
- ELTX $4.60
- 52 Week High
- POWW $2.14
- ELTX $12.62
- Technical
- Relative Strength Index (RSI)
- POWW 64.90
- ELTX 34.58
- Support Level
- POWW $1.67
- ELTX $8.60
- Resistance Level
- POWW $1.99
- ELTX $9.49
- Average True Range (ATR)
- POWW 0.10
- ELTX 0.49
- MACD
- POWW 0.02
- ELTX 0.02
- Stochastic Oscillator
- POWW 57.61
- ELTX 14.10
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.